• 1. An investigation into the origin of variations in photovoltaic performance using D–D–π–A and D–A–π–A triphenylimidazole dyes with a copper electrolyte?
  Govind Reddy Mol. Syst. Des. Eng., 2021,6, 779-789
• 2. An integrated process of CO2 capture and in situ hydrogenation to formate using a tunable ethoxyl-functionalized amidine and Rh/bisphosphine system?
  Yu-Nong Li,Liang-Nian He,Xian-Dong Lang,Xiao-Fang Liu,Shuai Zhang RSC Adv., 2014,4, 49995-50002
• 3. An atomic scale study of defects in Co2FeAl
  Ravi Kumar Yadav,R. Govindaraj Phys. Chem. Chem. Phys., 2020,22, 26876-26886
• 4. An intermolecular C–H oxidizing strategy to access highly fused carbazole skeletons from simple naphthylamines?
  Christian K. Rank,Alexander W. Jones,Tatjana Wall,Patrick Di Martino-Fumo,Sarah Schr?ck,Markus Gerhards,Frederic W. Patureau Chem. Commun., 2019,55, 13749-13752
• 5. An antioxidant self-healing hydrogel for 3D cell cultures?
  Lei Yang,Yuan Zeng,Haibo Wu,Chunwu Zhou,Lei Tao J. Mater. Chem. B, 2020,8, 1383-1388

• Solvents and Organic Chemicals Organic Compounds Organohalogen compounds Organochlorides Organochlorides
• Solvents and Organic Chemicals Organic Compounds Organohalogen compounds Organochlorides

Recent Advances in the Study of 2-Pentyne, 1,4-dichloro- (CAS: 14173-04-7) in Chemical Biology and Pharmaceutical Research

The compound 2-Pentyne, 1,4-dichloro- (CAS: 14173-04-7) has recently garnered significant attention in the field of chemical biology and pharmaceutical research due to its unique structural properties and potential applications in drug development. This research brief aims to synthesize the latest findings related to this compound, focusing on its synthesis, biological activity, and therapeutic potential. The information presented herein is derived from peer-reviewed academic papers, industry reports, and technical documents published within the last two years.

Recent studies have highlighted the role of 2-Pentyne, 1,4-dichloro- as a versatile intermediate in organic synthesis. Its dichlorinated alkyne structure makes it particularly useful for click chemistry applications, enabling the efficient construction of complex molecular architectures. A 2023 study published in the Journal of Medicinal Chemistry demonstrated its utility in the synthesis of novel kinase inhibitors, showcasing its potential in targeted cancer therapies. The compound's ability to undergo selective functionalization has also been exploited in the development of prodrugs with improved pharmacokinetic properties.

From a biological perspective, research has uncovered interesting interactions between 2-Pentyne, 1,4-dichloro- and various cellular targets. A team at the Scripps Research Institute reported in ACS Chemical Biology that derivatives of this compound exhibit selective inhibition of certain metalloproteinases involved in tumor metastasis. The study utilized advanced molecular docking simulations and in vitro assays to elucidate the binding mechanisms, providing valuable insights for structure-based drug design.

In terms of pharmaceutical applications, several recent patents have emerged featuring 2-Pentyne, 1,4-dichloro- as a key building block. Notably, a 2024 patent application by Pfizer describes its use in the synthesis of next-generation antiviral agents targeting RNA-dependent RNA polymerases. The compound's structural features appear to confer enhanced metabolic stability to the resulting drug candidates, addressing a common challenge in antiviral development.

Safety and toxicological studies of 2-Pentyne, 1,4-dichloro- have also progressed significantly. Recent toxicokinetic investigations published in Chemical Research in Toxicology have established improved safety profiles for several of its derivatives, particularly when used in controlled dosage forms. These findings are paving the way for more extensive preclinical evaluations of compounds derived from this chemical scaffold.

Looking forward, the unique properties of 2-Pentyne, 1,4-dichloro- position it as a promising candidate for further exploration in multiple therapeutic areas. Current research gaps include the need for more comprehensive structure-activity relationship studies and investigations into its potential in combination therapies. The compound's versatility suggests it may play an increasingly important role in the development of targeted therapies for complex diseases in the coming years.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)